ENTITY

Novavax (NVAX US)

13

Analysis

Health Care • United States

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

more

Refresh

Exchange Announcement • 19 Dec 2023 06:12

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 19 Dec 2023 06:09

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 19 Dec 2023 06:00

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 14 Dec 2023 06:00

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 14 Dec 2023 06:00

Initial statement of beneficial ownership of securities - general instructions (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1

x